CD44 and breast carcinoma: An association with survival has been demonstrated by one study [15] and gene signatures derived from CD44+ primary breast cancer cells and CD44+CD24- breast cancer cells (from xenografts or pleural effusions) have also been shown to correlate with outcome [35,36].